Intra-arterial infusions stand at the forefront of innovative medical interventions, serving as a strategic conduit for delivering specialized treatments directly to designated arteries. This advanced therapeutic approach involves the meticulous administration of medicinal compounds, ranging from potent drugs to imaging agents, directly into the arterial system. The distinctive advantage of intra-arterial infusions lies in their precision, enabling the concentration of therapeutic effects to a specific anatomical site. This targeted delivery mechanism not only enhances treatment efficacy but also minimizes the impact on the broader systemic circulation, paving the way for a more refined and personalized medical strategy. The integration of intra-arterial infusions is prominently featured in the realm of interventional medicine, where skilled practitioners harness its potential to address diverse medical conditions. Cancer treatments, in particular, benefit significantly from this technique, as it allows for the direct administration of chemotherapy drugs to the tumor site. Moreover, intra-arterial infusions find application in the realm of vascular disorders, contributing to the management of conditions such as arterial blockages or aneurysms.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation